Plaque Volume Over Stenosis Degree

Paradigms are bound to eventually change. After years blinded by stenosis degree, plaque volume has proven to be a better predictor of cardiovascular events and death. Thus, patients with similar degrees of atherosclerosis burden have a similar prognosis, regardless of their lesions being obstructive or not.

El volumen de placa por sobre el grado de estenosis

The aim of this work was to assess whether obstructive disease has an additional predictive value beyond its association with the total number of calcified atherosclerotic lesions evaluated by tomography.

This analysis, recently published in JACC, included 23,759 symptomatic patients diagnosed by angiography. Major cardiovascular events (infarction, stroke, and all-cause mortality) were stratified by atherosclerotic burden and number of affected vessels.

After a median follow-up of 4.3 years, 1054 patients experienced their first cardiovascular event. The event rate increased with both higher calcium scores and higher number of affected vessels. With a calcium score of 0, the event rate was 6.2 patients per 1000, while a >1000 score indicated a risk of 42.3 patients per 1000.

Having 1 affected vessel provided a similar risk of events than a calcium score of 0 (6.1 patients per 1000), while having all 3 vessels affected was not as severe as a calcium score >1000 (34.7 patients per 1000).


Read also: Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed.


After stratifying patients into 5 groups according to their calcium score (0, 1-99, 100-399, 400-1000, and >1000), the presence of obstructive disease was not associated with a higher risk when compared with patients without obstructive disease.

Conclusion

Plaque volume, and not stenosis per se, is the best predictor for cardiovascular events and death.

Original title: Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

Reference: Martin Bødtker Mortensen et al. J Am Coll Cardiol 2020;76:2803–13 https://doi.org/10.1016/j.jacc.2020.10.021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...